Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marilyn Skerda"'
Autor:
Ora H. Pescovitz, George R. Merriam, Marie C. Gelato, Saul Malozowski, Marilyn Skerda, Judith L. Ross, D. Lynn Loriaux, Fernando Cassorla
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 61:444-450
To assess the efficacy of GH-releasing hormone (GHRH) in the treatment of GH deficiency, we measured the effects of pulsatile iv GHRH administration on GH secretion, plasma levels of somatomedin-C (SmC), and short term linear growth (as determined by
Autor:
K. D. Hench, Gordon B. Cutler, D. L. Loriaux, Florence Comite, Marilyn Skerda, Ora H. Pescovitz, Andrew J. Dwyer, Kevin M. Barnes, Fernando Cassorla
Publikováno v:
Obstetrical & Gynecological Survey. 41:650-655
The long-acting analogue of luteinizing hormone releasing hormone, D-Trp 6 -Pro 9 -NEt-LHRH (LHRH a ), is effective in the short-term treatment of central precocious puberty. We report the results of two to four years of LHRH a therapy in 27 children
Autor:
Gordon B. Cutler, Marilyn Skerda, Wellington Hung, D. Lynn Loriaux, Ignace M. Valk, Fernando Cassorla
Publikováno v:
The Journal of clinical endocrinology and metabolism. 58(4)
To investigate the relative effects of androgens and estrogens on long bone growth, we evaluated the 3-week ulnar growth velocities of 10 boys before and after the iv administration of testosterone (T; 15 mg/day), dihydrotestosterone (DHT; 7 mg/day),
Autor:
Fernando Cassorla, Manuela Caruso-Nicoletti, D. Lynn Loriaux, Marilyn Skerda, Gordon B. Cutler, Judith L. Ross
Publikováno v:
The Journal of clinical endocrinology and metabolism. 61(5)
We previously described a biphasic dose-response curve for ethinyl estradiol on short term growth in patients with Turner's syndrome. To investigate whether there is a similar phenomenon in boys, we measured the 3-week ulnar growth velocity (TUG) aft
Autor:
Marilyn Skerda, Gordon B. Cutler, David Kurtz, D. Lynn Loriaux, Fernando Cassorla, Lauren Myerson Long, Judith L. Ross
Publikováno v:
The Journal of pediatrics. 109(6)
We randomly assigned 16 girls with Turner syndrome, age 5 to 15 years, to receive treatment with 100 ng/kg/day ethinyl estradiol or placebo for 6 months, with crossover after a 2-month interim period. We assessed growth by measurement of the 4-week l
Publikováno v:
The New England journal of medicine. 309(18)
PATIENTS with Turner's syndrome are short and lack a pubertal growth spurt.1 Estrogen has been implicated as one factor that stimulates the normal pubertal growth spurt, yet estrogen in high doses has also been used to inhibit growth.2 3 4 This sugge
Autor:
Marilyn Skerda, Lauren Myerson Long, Judith L. Ross, D. Lynn Loriaux, Gordon B. Cutler, Fernando Cassorla
Publikováno v:
The Journal of clinical endocrinology and metabolism. 63(4)
Short stature is a common feature of Turner’s syndrome. We studied the dose-response relationship between short term linear growth and GH dose using the lower legmeasuring device. Three doses of GH (0.05, 0.15, and 0.45 U/kg, three times weekly) we
Autor:
Ann McNEMAR, Merrily Poth, Ora H. Pescovitz, Florence Comite, Mark A. Sperling, K. D. Hench, Marilyn Skerda, D. Lynn Loriaux, Gordon B. Cutler, Fernando Cassorla, Andrew J. Dwyer
Publikováno v:
The Journal of clinical endocrinology and metabolism. 58(5)
Congenital adrenal hyperplasia (CAH) is a recognized cause of precocious pseudopuberty. Some children with CAH also develop true precocious puberty with early maturation of the hypothalamic-pituitary-gonadal axis. We have seen four such children (thr
Autor:
Judith L. Ross, Gordon B. Cutler, Fernando Cassorla, Ignace M. Valk, D. Lynn Loriaux, Marilyn Skerda
Publikováno v:
Obstetrical & Gynecological Survey. 39:291-292
Autor:
George R. Merriam, D. Lynn Loriaux, Marie C. Gelato, Penelope Feuillan, Judith L. Ross, Ora H. Pescovitz, Fernando Cassorla, Marilyn Skerda
Publikováno v:
Pediatric Research. 18:167A-167A
ACCELERATION OF LINEAR GROWTH AFTER REPEATED DOSES OF GROWTH HORMONE-RELEASING FACTOR (GRF)